Almost 2.3 million cases of chlamydia, gonorrhea, and syphilis were diagnosed in the United States in 2017, said the Centers CDC. This figure was boosted by a 45 percent increase among 15-24-year-old females. That surpasses the previous record set in 2016 by more than 200,000 cases.
"We're sliding backward", Jonathan Mermin, director of CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, said.
"We expect gonorrhea will eventually wear down our last highly effective antibiotic, and additional treatment options are urgently needed", said Gail Bolan, director of CDC's Division of STD Prevention.
Primary and secondary syphilis, of which there were 30,644 diagnoses in 2017, represented a 76 percent increase. A report has found that cases of syphilis, chlamydia, and gonorrhea have spiked for the fourth year in a row.
Chlamydia remained the most common STD reported, with more than 1.7 million cases in 2015.
David Harvey, executive director of the National Coalition of STD Directors, said the rise is due to stagnant federal funding for prevention efforts, a lack of screening and a decrease in condom use.
Gonorrhea diagnoses alone increased 67 percent and doubled among men.
"An STD expert says that President Trump should declare this a public health crisis".
More than 4 percent of gonorrhea samples were resistant to azithromycin in 2017, up from 1 percent in 2013.
Bolan cited another troubling statistic about the looming threat of antibiotic resistance regarding gonorrhea treatment. "We haven't seen anything like this for two decades".
Public health experts are also concerned about antibiotic resistant gonorrhea. To do that, we need the government to step up and ensure those working to prevent STDs have the resources they need to do so effectively.